Account
Articles
25.11.2015
Securing earlier patient access

The aim of MAPPs is to enable quicker access for patients whilst providing adequate and evolving evi...

Read more
Articles
24.07.2015
Cancer Drug Fund remit

The proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...

Read more
Articles
15.07.2015
The future of the Cancer Drug Fund

NHS England have recently proposed that NICE should take a more direct role in determining which pro...

Read more
News
27.02.2015
Includes Biosimilar discounts, recent developments

This issue includes topics such as the recent AIFA approval of Avastin for off label use in Wet-AMD ...

Read more
07.01.2015
NICE revises biosimilar guidance

NICE revises biosimilars guidance to conclude that they do not believe that biosimilars are identica...

Read more
Articles
21.11.2014
Presentation to EUCOPE members by Remap Consulting

Remap Consulting presents NICE's highly specialised technology methodology to EUCOPE

Read more
News
02.10.2014
Incl. latest news on NICE's Value Based Assessment

Updates on the latest news on NICE's Value Based Assessment, as well as the approval of ultra-orphan...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.